Cytokines in the pathogenesis of and protection against malaria

Clinical and Diagnostic Laboratory Immunology

Volumn 9, Issue 6, 2002, Pages 1145-1152

  Angulo, Iñigo ^a   Fresno, Manuel ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

HUMAN; IMMUNE RESPONSE; IMMUNITY; MALARIA; PATHOGENESIS; PLASMODIUM; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; SHORT SURVEY;

ANEMIA; ANIMALS; CYTOKINES; HUMANS; MALARIA; MALARIA, CEREBRAL; PROGNOSIS;

EID: 0036844617     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.9.6.1145-1152.2002     Document Type: Short Survey

References (109)

1. Adachi, K., H. Tsutsui, S. Kashiwamura, E. Seki, H. Nakano, O. Takeuchi, K. Takeda, K. Okumura, L. Van Kaer, H. Okamura, S. Akira, and K. Nakanishi. 2001. Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J. Immunol. 167:5928-5934.
2. Akanmori, B. D., J. A. Kurtzhals, B. Q. Goka, V. Adabayeri, M. F. Ofori, F. K. Nkrumah, C. Behr, and L. Hviid. 2000. Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria. Eur. Cytokine Netw. 11:113-118.
3. Alves, H. J., W. Weidanz, and L. Weiss. 1996. The spleen in murine Plasmodium chabaudi adami malaria: Stromal cells, T lymphocytes, and hematopoiesis. Am. J. Trop. Med. Hyg. 55:370-378.
4. Allan, R. J., P. Beattie, C. Bate, M. B. Van Hensbroek, S. Morris-Jones, B. M. Greenwood, and D. Kwiatkowski. 1995. Strain variation in tumor necrosis factor induction by parasites from children with acute falciparum malaria. Infect. Immun. 63:1173-1175.
5. Amani, V., A. M. Vigario, E. Belnoue, M. Marussig, L. Fonseca, D. Mazier, and L. Renia. 2000. Involvement of IFN-γ receptor-mediated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur. J. Immunol. 30:1646-1655.
6. Biemba, G., V. R. Gordeuk, P. Thuma, and G. Weiss. 2000. Markers of inflammation in children with severe malarial anaemia. Trop. Med. Int. Health. 5:256-262.
7. Brian de Souza, J., and E. M. Riley. 2002. Cerebral malaria: The contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect. 4:291-300.
8. Brown, H., G. Turner, S. Rogerson, M. Tembo, J. Mwenechanya, M. Molyneux, and T. Taylor. 1999. Cytokine expression in the brain in human cerebral malaria. J. Infect. Dis. 180:1742-1746.
9. Burgmann, H., S. Looareesuwan, E. C. Wiesinger, W. Winter, and W. Graninger. 1997. Levels of stem cell factor and interleukin-3 in serum in acute Plasmodium falciparum malaria. Clin. Diagn. Lab. Immunol. 4:226-228.
10. Carvalho, L. J., H. L. Lenzi, M. Pelajo-Machado, D. N. Oliveira, C. T. Daniel-Ribeiro, and M. F. Ferreira-da-Cruz. 2000. Plasmodium berghei: Cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes. Exp. Parasitol. 95:1-7.
11. Chotivanich, K., R. Udomsangpetch, A. Dondorp, T. Williams, B. Angus, J. A. Simpson, S. Pukrittayakamee, S. Looareesuwan, C. I. Newbold, and N. J. White. 2000. The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria. J. Infect. Dis. 182:629-633.
12. Choudhury, H. R., N. A. Sheikh, G. J. Bancroft, D. R. Katz, and J. B. De Souza. 2000. Early nonspecific immune responses and immunity to blood-stage nonlethal Plasmodium yoelii malaria. Infect. Immun. 68:6127-6132.
13. Clark, I. A., N. H. Hunt, G. A. Butcher, and W. B. Cowden. 1987. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-γ or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J. Immunol. 139:3493-3496.
14. Clark, I. A., and L. Schofield. 2000. Pathogenesis of malaria. Parasitol. Today 16:451-454.
15. Cross, C. E., and J. Langhorne. 1998. Plasmodium chabaudi chabaudi (AS): Inflammatory cytokines and pathology in an erythrocytic-stage infection in mice. Exp. Parasitol. 90:220-229.
16. Curfs, J. H., J. W. van der Meer, R. W. Sauerwein, and W. M. Eling. 1990. Low dosages of interteukin 1 protect mice against lethal cerebral malaria. J. Exp. Med. 172:1287-1291.
17. Day, N. P., T. T. Hien, T. Schollaardt, P. P. Loc, L. V. Chuong, T. T. Chau, N. T. Mai, N. H. Phu, D. X. Sinh, N. J. White, and M. Ho. 1999. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J. Infect. Dis. 180:1288-1297.
18. Deininger, M. H., P. G. Kremsner, R. Meyermann, and H. J. Schluesener. 2000. Differential cellular accumulation of transforming growth factor-β1, -β2, and -β3 in brains of patients who died with cerebral malaria. J. Infect. Dis. 181:2111-2115.
19. De Souza, J. B., K. H. Williamson, T. Otani, and J. H. Playfair. 1997. Early γ-interferon responses in lethal and nonlethal murine blood-stage malaria. Infect. Immun. 65:1593-1598.
20. Dockrell, H. M., J. B. De Souza, and J. H. Playfair. 1980. The role of the liver in immunity to blood-stage murine malaria. Immunology 41:421-430.
21. Dodoo, D., F. M. Omer, J. Todd, B. D. Akanmori, K. A. Koram, and E. M. Riley. 2002. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J. Infect. Dis. 185:971-979.
22. Dong, C., and R. A. Flavell. 2001. Th1 and Th2 cells. Curr. Opin. Hematol. 8:47-51.
23. Favre, N., B. Ryffel, G. Bordmann, and W. Rudin. 1997. The course of Plasmodium chabaudi chabaudi infections in interferon-γ receptor deficient mice. Parasite Immunol. 19:375-383.
24. Garcia, I., Y. Miyazaki, K. Araki, M. Araki, R, Lucas, G. E. Grau, G. Milon, Y. Belkaid, C. Montixi, W. Lesslauer, et al. 1995. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunol. 25:2401-2407.
25. Grau, G. E., K. Frei, P. F. Piguet, A. Fontana, H. Heremans, A. Billiau, P. Vassalli, and P. H. Lambert. 1990. Interleukin 6 production in experimental cerebral malaria: Modulation by anticytokine antibodies and possible role in hypergammaglobulinemia. J. Exp. Med. 172:1505-1508.
26. Haque, A., H, Echchannaoui, R, Seguin, J. Schwartzman, L. H. Kasper, and S. Haque. 2001. Cerebral malaria in mice: Interleukin-2 treatment induces accumulation of γδ T cells in the brain and alters resistant mice to susceptible-like phenotype. Am. J. Pathol. 158:163-172.
27. Helmby, H., M. Kullberg, and M. Troye-Blomberg. 1998. Expansion of IL-3-responsive IL-4-producing non-B non-T cells correlates with anemia and IL-3 production in mice infected with blood-stage Plasmodium chabaudi malaria. Eur. J. Immunol. 28:2559-2570.
28. Higuchi, T., N. Seki, S. Kamizono, A. Yamada, A. Kimura, H. Kato, and K. Itoh. 1998. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens 51:605-612.
29. Hoffman, S. L., J. M. Crutcher, S. K. Puri, A. A. Ansari, F. Villinger, E. D. Franke, P. P. Singh, F. Finkelman, M. K. Gately, G. P. Dutta, and M. Sedegah. 1997. Sterile protection of monkeys against malaria after administration of interleukin-12. Nat. Med. 3:80-83.
30. Jakobsen, P. H., V. McKay, S. D. Morris-Jones, W. McGuire, M. B. van Hensbroek, S. Meisner, K. Bendtzen, I. Schousboe, I. C. Bygbjerg, and B. M. Greenwood. 1994. Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of β-2-glycoprotein-I in Gambian children with cerebral malaria. Infect. Immun. 62:4374-4379.
31. Jakobsen, P. H., S. Morris-Jones, T. G. Theander, L. Hviid, M. B. Hansen, K. Bendtzen, R. G. Ridley, and B. M. Greenwood. 1994. Increased plasma levels of soluble IL-2R are associated with severe Plasmodium falciparum malaria. Clin. Exp. Immunol. 96:98-103.
32. Knight, J. C., I. Udalova, A. V. Hill, B. M. Greenwood, N. Peshu, K. Marsh, and D. Kwiatkowski. 1999. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat. Genet. 22:145-150.
33. Kobayashi, F., H. Ishida, T. Matsui, and M. Tsuji. 2000. Effects of in vivo administration of anti-IL-10 or anti-IFN-γ monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection. J. Vet. Med. Sci. 62:583-587.
34. Kobayashi, F., T. Morii, T. Matsui, T. Fujino, Y. Watanabe, W. P. Weidanz, and M. Tsuji. 1996. Production of interleukin 10 during malaria caused by lethal and nonlethal variants of Plasmodium yoelii yoelii. Parasitol. Res. 82:385-391.
35. Kossodo, S., C. Monso, P. Juillard, T. Velu, M. Goldman, and G. E. Grau. 1997. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 91:536-540.
36. Kumar, S., J. E. Epstein, T. L. Richie, F. K. Nkrumah, L. Soisson, D. J. Carucci, and S. L. Hoffman. 2002. A multilateral effort to develop DNA vaccines against falciparum malaria. Trends Parasitol. 18:129-135.
37. Kurtzhals, J. A., V. Adabayeri, B. Q. Goka, B. D. Akanmori, J. O. Oliver-Commey, F. K. Nkrumah, C. Behr, and L. Hviid. 1998. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351:1768-1772.
38. Kwiatkowski, D., A. V. Hill, I. Sambou, P. Twumasi, J. Castracane, K. R. Manogue, A. Cerami, D. R. Brewster, and B. M. Greenwood. 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336:1201-1204.
39. Lee, S. H., S. Looareesuwan, J. Chan, P. Wilairatana, S. Vanijanonta, S. M. Chong, and B. H. Chong. 1997. Plasma macrophage colony-stimulating factor and P-selectin levels in malaria-associated thrombocytopenia. Thromb. Haemost. 77:289-293.
40. Li, C., I. Corraliza, and J. Langhorne. 1999. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 67:4435-4442.
41. Li, C., and J. Langhorne. 2000. Tumor necrosis factor α p55 receptor is important for development of memory responses to blood-stage malaria infection. Infect. Immun. 68:5724-5730.
42. Linke, A., R. Kuhn, W. Muller, N. Honarvar, C. Li, and J. Langhorne. 1996. Plasmodium chabaudi chabaudi: Differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp. Parasitol. 84:253-263.
43. ab used as an ancillary treatment for severe malaria. Am. J. Trop. Med. Hyg. 61:26-33.
44. Lou, J., R. Lucas, and G. E. Grau. 2001. Pathogenesis of cerebral malaria: Recent experimental data and possible applications for humans. Clin. Microbiol. Rev. 14:810-820.
45. Lucas, B., L. H. Kasper, K. Smith, and A. Haque. 1996. In vivo treatment with interleukin 2 reduces parasitemia and restores IFN-γ gene expression and T-cell proliferation during acute murine malaria. C. R. Acad. Sci. III 319:705-710.
46. Lucas, R., P. Juillard, E. Decoster, M. Redard, D. Burger, Y. Donati, C. Giroud, C. Monso-Hinard, T. De Kesel, W. A. Buurman, M. W. Moore, J. M. Dayer, W. Fiers, H. Bluethmann, and G. E. Grau. 1997. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur. J. Immunol. 27:1719-1725.
47. Luty, A. J., B. Lell, R. Schmidt-Ott, L, G, Lehman, D. Luckner, B. Greve, P. Matousek, K. Herbich, D. Schmid, F. Migot-Nabias, P. Deloron, R. S. Nussenzweig, and P. G. Kremsner, 1999. Interferon-γ responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J. Infect. Dis. 179:980-988.
48. Luty, A. J., D. J. Perkins, B. Lell, R. Schmidt-Ott, L. G. Lehman, D. Luckner, B. Greve, P. Matousek, K. Herbich, D. Schmid, J. B. Weinberg, and P. G. Kremsner. 2000. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect. Immun. 68:3909-3915.
49. Maggio-Price, L., D. Brookoff, and L. Weiss. 1985. Changes in hematopoietic stem cells in bone marrow of mice with Plasmodium berghei malaria. Blood 66:1080-1085.
50. Maneerat, Y., E. Pongponratn, P. Viriyavejakul, B. Punpoowong, S. Looareesuwan, and R. Udomsangpetch. 1999. Cytokines associated with pathology in the brain tissue of fatal malaria. Southeast Asian J. Trop. Med. Public Health 30:643-649.
51. Martiney, J. A., B. Sherry, C. N. Metz, M. Espinoza, A. S. Ferrer, T. Calandra, H. E. Broxmeyer, and R. Bucala. 2000. Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: Possible role in the pathogenesis of malarial anemia. Infect. Immun. 68:2259-2267.
52. May, J., B. Lell, A. J. Luty, C. G. Meyer, and P. G. Kremsner. 2000. Plasma interleukin-10:tumor necrosis factor (TNF)-α ratio is associated with TNF promoter variants and predicts malarial complications. J. Infect. Dis. 182:1570-1573.
53. McGuire, W., U. D'Alessandro, S. Stephens, B. O. Olaleye, P. Langerock, B. M. Greenwood, and D. Kwiatkowski. 1998. Levels of tumour necrosis factor and soluble TNF receptors during malaria fever episodes in the community. Trans. R. Soc. Trop. Med. Hyg. 92:50-53.
54. McGuire, W., A. V. Hill, C. E. Allsopp, B. M. Greenwood, and D. Kwiatkowski. 1994. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371:508-510.
55. Medana, I. M., N. H. Hunt, and G. Chaudhri. 1997. Tumor necrosis factor-α expression in the brain during fatal murine cerebral malaria: Evidence for production by microglia and astrocytes. Am. J. Pathol. 150:1473-1486.
56. Miller, L. H., D. I. Baruch, K. Marsh, and O. K. Doumbo. 2002. The pathogenic basis of malaria. Nature 415:673-679.
57. Mohan, K., H. Sam, and M. M. Stevenson. 1999. Therapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection. Infect. Immun. 67:513-519.
58. Mohan, K., and M. M. Stevenson. 1998. Acquired immunity to asexual blood stages in malaria, p. 467-493. In I. W. Sherman (ed.), Parasite Biology, Pathogenesis, and Protection. ASM Press, Washington, D.C.
59. Mohan, K., and M. M. Stevenson. 1998. Dyserythropoiesis and severe anaemia associated with malaria correlate with deficient interleukin-12 production, Br. J. Haematol. 103:942-949.
60. Mohan, IC, and M. M. Stevenson. 1998. Interleukin-12 corrects severe anemia during blood-stage Plasmodium chabaudi AS in susceptible A/J mice. Exp. Hematol. 26:45-52.
61. Mordmuller, B. G., W. G. Metzger, P. Juillard, B. M. Brinkman, C. L. Verweij, G. E. Grau, and P. G. Kremsner. 1997. Tumor necrosis factor in Plasmodium falciparum malaria: High plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur. Cytokine Netw. 8:29-35,
62. Muniz-Junqueira, M. I., L. L. dos Santos-Neto, and C. E. Tosta. 2001. Influence of tumor necrosis factor-α on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro. Cell. Immunol. 208:73-79.
63. Naik, R. S., O. H. Branch, A. S. Woods, M. Vijaykumar, D. J. Perkins, B. L. Nahlen, A. A. Lal, R. J. Cotter, C. E. Costello, C. F. Ockenhouse, E. A. Davidson, and D. C. Gowda. 2000. Glycosylphosphatidylinositol anchors of Plasmodium falciparum: Molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J. Exp. Med. 192:1563-1576.
64. Nakanishi, K., T. Yoshimoto, H. Tsutsui, and H. Okamura. 2001. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19:423-474.
65. Omer, F. M., and E. M. Riley. 1998. Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. J. Exp. Med. 188:39-48.
66. Othoro, C., A. A. Lal, B. Nahlen, D. Koech, A. S. Orago, and V. Udhaya-kumar. 1999. A low interleukin-10 tumor necrosis factor-α ratio is associated with malaria anemia in children residing in a holoendernic malaria region in Western Kenya. J. Infect. Dis. 179:279-282.
67. Pasparakis, M., S. Kousteni, J. Peschon, and G. Kollias. 2000. Tumor necrosis factor and the p55 TNF receptor are required for optimal development of the marginal sinus and for migration of follicular dendritic cell precursors into splenic follicles. Cell. Immunol. 201:33-41.
68. Perkins, D. J., P. G. Kremsner, D. Schmid, M. A. Misukonis, M. A. Kelly, and J. B. Weinberg. 1999. Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria. Infect. Immunn. 67:4977-4981.
69. Perkins, D. J., J. B. Weinberg, and P. G. Kremsner. 2000. Reduced interleukin-12 and transforming growth factor-β1 in severe childhood malaria: Relationship of cytokine balance with disease severity. J. Infect. Dis. 182:988-992.
70. Perlmann, P., H. Perlmann, G. ElGhazali, and M. T. Blomberg. 1999. IgE and tumor necrosis factor in malaria infection. Immunol. Lett. 65:29-33.
71. Piguet, P. F., C. D. Kan, C. Vesin, A. Rochat, Y. Donati, and C. Barazzone. 2001. Role of CD40-CD40L in mouse severe malaria. Am. J. Pathol. 159:733-742.
72. Postma, N. S., C. C. Hermsen, D. J. Crommelin, J. Zuidema, and W. M. Eling. 1999. Treatment with recombinant human tumour necrosis factor-α reduces parasitaemia and prevents Plusmodium berghei K173-induced experimental cerebral malaria in mice. Parasitology 118:7-15.
73. Richie, T. L., and A. Saul. 2002. Progress and challenges for malaria vaccines. Nature 415:694-701.
74. Riopel, J., M. Tam, K. Mohan, M. W. Marino, and M. M. Stevenson. 2001. Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria. Infect. Immunol. 69:129-136.
75. Rudin, W., N. Favre, G. Bordmann, and B. Ryffel. 1997. Interferon-γ is essential for the development of cerebral malaria. Eur. J. Immunol. 27:810-815.
76. Sam, H., and M. M. Stevenson. 1999. Early IL-12 p70, but not p40, production by splenic macrophages correlates with host resistance to blood-stage Plasmodium chabaudi AS malaria. Clin. Exp. Immunol. 117:343-349.
77. Sam, H., and M. M. Stevenson. 1999. In vivo IL-12 production and IL-12 receptors betal and beta2 mMRNA expression in the spleen are differentially upregulated in resistant B6 and susceptible A/J mice during early blood-stage Plasmodium chabaudi AS malaria. J. Immunol. 162:1582-1589.
78. Sam, H., Z. Su, and M. M. Stevenson. 1999. Deficiency in tumor necrosis factor α activity does not impair early protective Th1 responses against blood-stage malaria. Infect. Immun. 67:2660-2664.
79. Sarthou, J. L., G. Angel, G. Aribot, C. Rogier, A. Dieye, A. Toure Balde, B. Diatta, P. Seignot, and C. Roussilhon. 1997. Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria. Infect. Immun. 65:3271-3276.
80. Schofield, L., and F. Hackett. 1993. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J. Exp. Med. 177:145-153.
81. Schofield, L., L. Vivas, F. Hackett, P. Gerold, R. T. Schwarz, and S. Tachado. 1993. Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNF-α-inducing toxin of Plasmodium falciparum: Prospects for the immunotherapy of severe malaria. Ann. Trop. Med. Parasitol. 87:617-626.
82. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin 12 induction of interferon γ-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700-10702.
83. Seixas, E. M., and J. Langhorne. 1999. γδ T cells contribute to control of chronic parasitemia in Plasmodium chabaudi infections in mice. J. Immunol. 162:2837-2841.
84. Senaldi, G., C. L. Shaklee, J. Guo, L. Martin, T. Boone, T. W. Mak, and T. R. Ulich. 1999. Protection against the mortality associated with disease models mediated by TNF-α and IFN-γ in mice lacking IFN regulatory factor-1. J. Immunol. 163:6820-6826.
85. Shear, H. L., M. W. Marino, C. Wanidworanun, J. W. Berman, and R. L. Nagel. 1998. Correlation of increased expression of intercellular adhesion molecule-1, but not high levels of tumor necrosis factor-α, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria. Am. J. Trop. Med. Hyg. 59:852-858.
86. Singh, R. P., S. Kashiwamura Si, P. Rao, H. Okamura, A. Mukherjee, and V. S. Chauhan. 2002. The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA. J. Immunol. 168:4674-4681.
87. Stevenson, M. M., and E. Ghadirian. 1989. Human recombinant tumor necrosis factor-α protects susceptible A/J mice against lethal Plasmodium chabaudi AS infection. Infect. Immun. 57:3936-3939.
88. Stevenson, M. M., M. F. Tam, S. F. Wolf, and A. Sher. 1995. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155:2545-2556.
89. Su, Z., and M. M. Stevenson. 2000. Central role of endogenous γ-interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection. Infect. Immun. 68:4399-4406.
90. Su, Z., and M. M. Stevenson. 2002. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice. J. Immunol. 168:1348-1355.
91. Tan, R. S., C. Feng, Y. Asano, and A. U. Kara, 1999. Altered immune response of interferon regulatory factor 1-deficient mice against Plasmodium berghei blood-stage malaria infection. Infect. Immum. 67:2277-2283.
92. Tan, R. S.,A. U. Kara, C. Feng, Y. Asano, and R. Sinniah. 2000. Differential interleukin-10 expression in interferon regulatory factor-1 deficient mice during Plasmodium berghei blood-stage infection. Parasite Immunol. 22:425-435.
93. Taverne, J., H. M. Dockrell, and J. H. Playfair. 1982. Killing of the malarial parasite P/asmodium yoetii in vitro by cells of myeloid origin. Parasite Immunol. 4:77-91.
94. Thuma, P. E., G. Weiss, M. Herold, and V. R. Gordeuk. 1996. Serum neopterin, interleukin-4, and interleukin-6 concentrations in cerebral malaria patients and the effect of iron chelation therapy. Am. J. Trop. Med. Hyg. 54:164-168.
95. Tongren, J. E., C. Yang, W. E. Collins, J. S. Sullivan, A. A. Lal, and L. Xiao. 2000. Expression of proinflarnmatory cytokines in four regions of the brain in Macaque mulatta (rhesus) monkeys infected with Plasmodium coatneyi. Am. J. Trop. Med. Hyg. 62:530-534.
96. Torre, D., F. Speranza, M. Giola, A. Matteelli, R. Tambini, and G. Biondi. 2002. Role of Th1 and Th2 cytokines in immune response to uncomplicated Plasmodium falciparum malaria. Clin. Diagn. Lab. Immunol. 9:348-351.
97. Troye-Blomberg, M., K. Berzins, and P. Perlmann. 1994. T-cell control of immunity to the asexual blood stages of the malaria parasite. Crit. Rev. Immunol. 14:131-155.
98. Tsutsui, N., and T. Kamiyama. 1999. Transforming growth factor β-induced failure of resistance to infection with blood-stage Plasmodium chabaudi in mice. Infect. Immun. 67:2306-2311.
99. Ubalee, R., F. Suzuki, M. Kikuchi, O. Tasanor, Y. Wattanagoon, R. Ruangweerayut, K. Na-Bangchang, J. Karbwang, A. Kimura, K. Itoh, T. Kanda, and K. Hirayama. 2001. Strong association of a tumor necrosis factor-α promoter allele with cerebral malaria in Myanmar. Tissue Antigens 58:407-410.
100. Wenisch, C., K. F. Linnau, S. Looaresuwan, and H. Rumpold. 1999. Plasma levels of the interleukin-6 cytokine family in persons with severe Plasmodium falciparum malaria. J. Infect. Dis. 179:747-750.
101. Wilson, A. G., J. A. Symons, T. L. McDowell, H. O. McDevitt, and G. W. Duff. 1997. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94:3195-3199.
102. Yadava, A., S. Kumar, J. A. Dvorak, G. Milon, and L. H. Miller. 1996. Trafficking of Plasmodium chabaudi adami-infected erythrocytes within the mouse spleen. Proc. Natl. Acad. Sci. USA 93:4595-4599.
103. Yanez, D. M., D. D. Manning, A. J. Cooley, W. P. Weidanz, and H. C. van der Heyde. 1996. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J. Immunol. 157:1620-1624.
104. Yap, G. S., and M. M. Stevenson. 1994. Inhibition of in vitro erythropoiesis by soluble mediators in Plasmodium chabaudi AS malaria: Lack of a major role for interleukin 1, tumor necrosis factor α, and γ interferon. Infect. Immun. 62:357-362.
105. Yap, G. S., and M. M. Stevenson. 1991. Production of soluble inhibitor of erythropoiesis during Plasmodium chabaudi AS infection in resistant and susceptible mice. Ann. N. Y. Acad. Sci. 628:279-281.
106. Yoneto, T., T. Yoshimoto, C. R. Wang, Y. Takahama, M. Tsuji, S. Waki, and H. Nariuchi. 1999. Gamma-interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical. Infect. Immun. 67:2349-2356.
107. Yoshida, A., H. Maruyama, T. Kumagai, T. Amano, F. Kobayashi, M. Zhang, K. Himeno, and N. Ohta. 2000. Schistosoma mansoni infection cancels the susceptibility to Plasmodium chabaudi through induction of type 1 immune responses in A/J mice. Int. Immunol. 12:1117-1125.
108. Yoshimoto, T., Y. Takahama, C. R. Wang, T. Yoneto, S. Waki, and H. Nariuchi. 1998. A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection. J. Immunol. 160:5500-5505.
109. Yoshimoto, T., T. Yoneto, S. Waki, and H. Nariuchi. 1998. Interleukin-12-dependent mechanisms in the clearance of blood-stage murine malaria parasite Plasmodium berghei XAT, an attenuated variant of P. berghei NK65. J. Infect. Dis. 177:1674-1681.